Inhaled PA9159 for Adults with Moderate Asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new inhaled medicine called PA9159 for adults with moderate asthma. It compares the medicine to a placebo to see if it safely improves breathing and controls asthma symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with asthma by a doctor.
- Your lung function tests show that your asthma is moderate (FEV1 between 60% and 85% of normal).
- You have had a positive test showing that your airways can relax with medication, or have daily peak flow variability over 10%.
- You are able to use a nebulizer correctly.
- You have not had an asthma flare-up needing steroids in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled asthma medication, PA9159, in adults with stable or mild-to-moderate asthma. It aims to see if the drug improves lung function and is safe. You may qualify if you have asthma with some airflow limitation and have not had recent severe flare-ups.
This study tests two ways to use common asthma inhalers (budesonide and formoterol) to see if a simple, everyday approach can control mild asthma symptoms better and with less need for rescue medicine.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
This study tests a new three-part asthma inhaler (CHF 5993) in people whose asthma isn't well-controlled even though they're already using two standard asthma medicines together. The goal is to see if adding this new medicine helps control asthma better.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.